RU2020117900A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2020117900A3 RU2020117900A3 RU2020117900A RU2020117900A RU2020117900A3 RU 2020117900 A3 RU2020117900 A3 RU 2020117900A3 RU 2020117900 A RU2020117900 A RU 2020117900A RU 2020117900 A RU2020117900 A RU 2020117900A RU 2020117900 A3 RU2020117900 A3 RU 2020117900A3
- Authority
- RU
- Russia
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762580742P | 2017-11-02 | 2017-11-02 | |
| US62/580,742 | 2017-11-02 | ||
| US201862643063P | 2018-03-14 | 2018-03-14 | |
| US62/643,063 | 2018-03-14 | ||
| PCT/US2018/058957 WO2019090076A1 (en) | 2017-11-02 | 2018-11-02 | Modulators of the integrated stress pathway |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2020117900A RU2020117900A (ru) | 2021-12-02 |
| RU2020117900A3 true RU2020117900A3 (enExample) | 2022-05-18 |
Family
ID=64564980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2020117900A RU2020117900A (ru) | 2017-11-02 | 2018-11-02 | Модуляторы интегрированного стресса |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20200345727A1 (enExample) |
| EP (1) | EP3710428B1 (enExample) |
| JP (1) | JP2021501786A (enExample) |
| KR (1) | KR20200096522A (enExample) |
| CN (1) | CN112204009B (enExample) |
| AU (2) | AU2018360857A1 (enExample) |
| BR (1) | BR112020008839A2 (enExample) |
| CA (1) | CA3080806A1 (enExample) |
| CL (1) | CL2020001167A1 (enExample) |
| CO (1) | CO2020006248A2 (enExample) |
| EC (1) | ECSP20026381A (enExample) |
| IL (1) | IL274369B2 (enExample) |
| MX (1) | MX2020004555A (enExample) |
| PE (1) | PE20210396A1 (enExample) |
| PH (1) | PH12020550523A1 (enExample) |
| RU (1) | RU2020117900A (enExample) |
| SG (1) | SG11202003982QA (enExample) |
| TW (1) | TWI797186B (enExample) |
| UY (1) | UY37957A (enExample) |
| WO (1) | WO2019090076A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3512839A4 (en) | 2016-09-18 | 2020-03-25 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | AGAINST INTERACTION OF YAP1 WITH YCT1 INHIBITORS |
| IL301709B2 (en) | 2017-08-09 | 2025-07-01 | Denali Therapeutics Inc | Compounds, compositions and methods |
| TW201920129A (zh) | 2017-09-01 | 2019-06-01 | 美商戴納立製藥公司 | 化合物、組合物及方法 |
| KR20190043437A (ko) | 2017-10-18 | 2019-04-26 | 씨제이헬스케어 주식회사 | 단백질 키나제 억제제로서의 헤테로고리 화합물 |
| JP2021501785A (ja) | 2017-11-02 | 2021-01-21 | カリコ ライフ サイエンシーズ エルエルシー | 統合的ストレス経路の調節剤 |
| JP2021508336A (ja) | 2017-12-13 | 2021-03-04 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路の阻害剤 |
| WO2019178401A1 (en) | 2018-03-14 | 2019-09-19 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Yap1 inhibitors that target the interaction of yap1 with oct4 |
| US11166942B2 (en) | 2018-06-05 | 2021-11-09 | Praxis Biotech LLC | Inhibitors of integrated stress response pathway |
| TW202545902A (zh) | 2018-10-11 | 2025-12-01 | 美商嘉來克生命科學有限責任公司 | 整合應激路徑之前藥調節劑 |
| KR102195348B1 (ko) | 2018-11-15 | 2020-12-24 | 에이치케이이노엔 주식회사 | 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물 |
| BR112021013924A2 (pt) | 2019-01-18 | 2021-09-21 | Astrazeneca Ab | Inibidores de pcsk9 e métodos de uso do mesmo |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
| CR20210426A (es) | 2019-02-13 | 2021-09-30 | Denali Therapeutics Inc | Compuestos, composiciones y métodos |
| EP3924341A4 (en) | 2019-02-13 | 2022-11-02 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| WO2020216766A1 (en) | 2019-04-23 | 2020-10-29 | Evotec International Gmbh | Modulators of the integrated stress response pathway |
| MX2021012904A (es) | 2019-04-23 | 2022-01-18 | Evotec Int Gmbh | Moduladores de la via de respuesta al estres integrada. |
| AR118836A1 (es) * | 2019-04-30 | 2021-11-03 | Calico Life Sciences Llc | Moduladores de la vía de tensión integrada |
| JP2022536663A (ja) | 2019-06-12 | 2022-08-18 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路のモジュレーター |
| US20230029266A1 (en) * | 2019-11-05 | 2023-01-26 | Dermira, Inc. | MrgprX2 Antagonists for the Treatment of Inflammatory Disorders |
| CA3162526A1 (en) | 2020-01-28 | 2021-08-05 | Christopher John Brown | Modulators of the integrated stress response pathway |
| KR20220151635A (ko) | 2020-03-11 | 2022-11-15 | 에보텍 인터내셔널 게엠베하 | 통합 스트레스 반응 경로의 조절제 |
| CN113754541B (zh) * | 2020-06-02 | 2025-01-03 | 深圳湾实验室 | 靶向eb病毒核抗原蛋白的小分子抑制剂、制备方法及其应用 |
| ES2997335T3 (en) | 2020-10-22 | 2025-02-17 | Evotec Int Gmbh | Modulators of the integrated stress response pathway |
| CA3195290A1 (en) | 2020-10-22 | 2022-04-28 | Holly Victoria Atton | Modulators of the integrated stress response pathway |
| MX2023004677A (es) | 2020-10-22 | 2023-05-24 | Evotec Int Gmbh | Moduladores de la via de respuesta integrada al estres. |
| TW202241857A (zh) | 2020-12-18 | 2022-11-01 | 美商戴納立製藥公司 | 化合物之固體形式 |
| TW202329937A (zh) | 2021-12-03 | 2023-08-01 | 美商英塞特公司 | 雙環胺ｃｋ１２抑制劑 |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
| EP4480477A4 (en) * | 2022-02-15 | 2025-06-18 | Kanaph Therapeutics Inc. | Pharmaceutical composition for treating cancer, comprising anticancer agent and novel compound having inhibitory activity with respect to prostaglandin e2 receptors |
| CN114614096B (zh) * | 2022-02-24 | 2024-03-08 | 复旦大学 | 一种快充型电解液及其在锂离子电池中的应用 |
| PE20250789A1 (es) * | 2022-03-30 | 2025-03-14 | Escient Pharmaceuticals Inc | Derivados de quinolina como moduladores del receptor x2 de la proteina g relacionados con mas y productos relacionados |
| WO2023211854A1 (en) * | 2022-04-25 | 2023-11-02 | Praxis Precision Medicines, Inc. | Kcnt1 inhibitors comprising a thiazole core and methods of use |
| JP2025514140A (ja) * | 2022-04-25 | 2025-05-02 | プラクシス プレシジョン メディシンズ， インコーポレイテッド | ピラゾールコアを含むｋｃｎｔ１阻害剤及び使用方法 |
| CN115368263B (zh) * | 2022-09-01 | 2024-05-17 | 南开大学 | 一种肉桂酸酰胺衍生物的合成及其制药应用 |
| CN121263408A (zh) * | 2023-07-14 | 2026-01-02 | 深圳众格生物科技有限公司 | 一种化合物、包含其的药物组合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1026506A (en) * | 1962-10-17 | 1966-04-20 | Du Pont | Bicyclodiamines and preparation thereof |
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| ES2668834T3 (es) * | 2008-09-08 | 2018-05-22 | Merck Serono Sa | Pirimidinas macrociclicas como inhibidores de proteína quinasas |
| WO2011087758A1 (en) * | 2009-12-22 | 2011-07-21 | H. Lundbeck A/S | Adamantyl amide derivatives and uses of same |
| TWI538905B (zh) * | 2010-12-22 | 2016-06-21 | Ｈ 朗德貝克公司 | 雙環［３．２．１］辛基醯胺衍生物及其用途 |
| SI2861566T1 (sl) * | 2012-06-13 | 2017-03-31 | F. Hoffmann-La Roche Ag | Novi diazaspirocikloalkan in azaspirocikloalkan |
| WO2014144952A2 (en) * | 2013-03-15 | 2014-09-18 | Peter Walter | Modulators of the eif2alpha pathway |
| WO2015038778A1 (en) * | 2013-09-11 | 2015-03-19 | The Brigham And Women's Hospital, Inc. | SUBSTITUTED UREA EIF2α KINASE ACTIVATORS |
| TW201808888A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
-
2018
- 2018-11-01 UY UY0001037957A patent/UY37957A/es not_active Application Discontinuation
- 2018-11-02 MX MX2020004555A patent/MX2020004555A/es unknown
- 2018-11-02 PE PE2020000686A patent/PE20210396A1/es unknown
- 2018-11-02 AU AU2018360857A patent/AU2018360857A1/en not_active Abandoned
- 2018-11-02 SG SG11202003982QA patent/SG11202003982QA/en unknown
- 2018-11-02 US US16/761,390 patent/US20200345727A1/en not_active Abandoned
- 2018-11-02 CN CN201880085382.9A patent/CN112204009B/zh active Active
- 2018-11-02 RU RU2020117900A patent/RU2020117900A/ru unknown
- 2018-11-02 IL IL274369A patent/IL274369B2/en unknown
- 2018-11-02 CA CA3080806A patent/CA3080806A1/en active Pending
- 2018-11-02 WO PCT/US2018/058957 patent/WO2019090076A1/en not_active Ceased
- 2018-11-02 KR KR1020207015791A patent/KR20200096522A/ko not_active Ceased
- 2018-11-02 TW TW107138954A patent/TWI797186B/zh active
- 2018-11-02 BR BR112020008839-0A patent/BR112020008839A2/pt not_active IP Right Cessation
- 2018-11-02 EP EP18811984.6A patent/EP3710428B1/en active Active
- 2018-11-02 JP JP2020524813A patent/JP2021501786A/ja active Pending
-
2020
- 2020-04-30 PH PH12020550523A patent/PH12020550523A1/en unknown
- 2020-05-04 CL CL2020001167A patent/CL2020001167A1/es unknown
- 2020-05-15 EC ECSENADI202026381A patent/ECSP20026381A/es unknown
- 2020-05-22 CO CONC2020/0006248A patent/CO2020006248A2/es unknown
-
2023
- 2023-04-28 AU AU2023202592A patent/AU2023202592C1/en active Active
- 2023-06-06 US US18/330,185 patent/US20240307382A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR102023005164A2 (enExample) | ||
| BR102022025291A2 (enExample) | ||
| BR112025024041B1 (pt) | Elemento de despejamento para uma embalagem compósita e embalagem compósita com um elemento de despejamento | |
| BR112025008516B1 (pt) | Método tudo em um de recuperação de níquel para recuperar níquel a partir de matérias-primas contendo níquel | |
| BR112025016688B1 (pt) | Compostos e composições farmacêuticas | |
| BR112025011041B1 (pt) | Dispositivo para inspeção de um elemento roscado e método de inspeção correspondente | |
| BR112024022558B1 (pt) | Polipeptídeo, polinucleotídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, e, método in vitro para aumentar adesão celular | |
| BR112025005915B1 (pt) | Gerador, dispositivo e método de ablação de campo pulsado | |
| BR112025005363B1 (pt) | Equipamento de usuário, entidade de rede e métodos relacionados | |
| BR102023016405B1 (pt) | Estrutura de viga de pá, pá de energia eólica e equipamento de energia eólica | |
| BR112024026850B1 (pt) | Triturador de mandíbula e método de serviço ou de manutenção de um triturador de mandíbula | |
| BR112024025233B1 (pt) | Método para alterar o estado de elevação vertical para um veículo transportador, controle e veículo | |
| BR102023009702B1 (pt) | Dispositivo para alisamento e aplicação de substância de tratamento | |
| BR112024027500B1 (pt) | Polipeptídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, uso do polipeptídeo, e, método para promover a proliferação de uma célula in vitro | |
| BR112024018530B1 (pt) | Método para determinar nível de escória do alto-forno, método para operar alto-forno e unidade de controle | |
| BR112024027130B1 (pt) | Sistema e método para um conjunto de cuff (balão) de tubo endotraqueal | |
| BR112025001284B1 (pt) | Cabo, sistema de sensor e método de montagem de um alojamento de sensor | |
| BR102022024748B1 (pt) | Equipamento extrator de esporos da superfície de grãos de cereal para aplicação em laboratório e seu processo operacional | |
| BR122025008973A2 (pt) | Sistema, método para decodificar um vídeo e mídia legível por computador | |
| BR122025008970A2 (pt) | Método para decodificar um vídeo, sistema e mídia legível por computador | |
| BR122025008972A2 (pt) | Sistema, método para decodificar um vídeo e mídia legível por computador | |
| BR102022012728B1 (pt) | Unidade para visualização do reinício de escoamento de fluidos dependentes do tempo | |
| BR102022009310B1 (pt) | Sistema de montagem para as linhas de adubo de implementos agrícolas | |
| BR102022001501B1 (pt) | Sistema de segurança embarcado em boias meteoceanográficas ou correlatos | |
| BR112023000644B1 (pt) | Dispositivos vestíveis |